Inactive Instrument
Precision Therapeutics Inc Stock Nasdaq
Stocks
US74033P1003
Biotechnology & Medical Research
| Market Cap | 140M 124M 116M 106M 200M 13.46B 201M 1.41B 545M 6.88B 526M 514M 22.08B | P/E 2026 * |
-6.94x | P/E 2027 * | -110x |
|---|---|---|---|---|---|
| Enterprise Value | 140M 124M 116M 106M 200M 13.46B 201M 1.41B 545M 6.88B 526M 514M 22.08B | EV / Sales 2026 * |
2.32x | EV / Sales 2027 * | 0.32x |
| Free-Float |
94.04% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Precision Therapeutics Inc
| 1 day | -7.56% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 2026-02-08 | |
| Director of Finance/CFO | - | 2026-04-15 | |
Kyle Okamoto
PSD | President | - | 2026-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Handley
BRD | Director/Board Member | 66 | 2020-02-18 |
Charles Nuzum
CHM | Chairman | 78 | 2026-02-08 |
| Director/Board Member | 60 | 2020-07-08 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.56% | -8.33% | - | - | 140M | ||
| +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | ||
| -3.11% | -3.53% | +20.19% | +81.44% | 57.39B | ||
| +0.89% | -0.63% | +2.17% | +36.19% | 47.64B | ||
| +0.36% | +0.81% | +342.39% | +742.40% | 44.29B | ||
| -0.96% | -4.50% | +24.96% | +35.38% | 42.5B | ||
| -0.20% | -0.77% | +4.13% | +105.50% | 40.71B | ||
| -0.54% | +2.93% | +9.31% | +50.41% | 30.97B | ||
| -2.68% | +2.92% | +29.33% | +22.72% | 28.53B | ||
| +0.05% | -1.64% | -8.14% | -11.37% | 24.34B | ||
| Average | -0.96% | -0.59% | +52.63% | +128.54% | 43.39B | |
| Weighted average by Cap. | +0.12% | -0.84% | +56.96% | +138.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 60.4M 53.67M 50.09M 45.65M 86.1M 5.81B 86.9M 606M 235M 2.97B 227M 222M 9.53B | 431M 383M 358M 326M 615M 41.46B 621M 4.33B 1.68B 21.2B 1.62B 1.58B 68.03B |
| Net income | -41.4M -36.78M -34.33M -31.29M -59.02M -3.98B -59.57M -415M -161M -2.03B -155M -152M -6.53B | -4.5M -4M -3.73M -3.4M -6.41M -433M -6.47M -45.16M -17.5M -221M -16.9M -16.53M -710M |
| Net Debt | - | - |
Employees
-
















